We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance to Develop New DNA Diagnostic Tools

By HospiMedica staff writers
Posted on 22 Mar 2001
A broad five-year alliance in the field of DNA-based diagnostics has been formed by deCode genetics (Reykjavik, Iceland) and Roche Diagnostics (Basel, Switzerland). More...
The alliance builds on decode's unique population genomics resources and bioinformatics expertise and on the global leadership of Roche in the field of molecular diagnostics.

The two companies will use the genomics research and informatics of decode to develop an integrated suite of new diagnostic products and services for diagnosing common diseases and for predicting individual predisposition. The partners will also develop point-of-care informatics products and services that will help doctors evaluate DNA-based test results, in order to optimize the early treatment and prevention of disease.

"By bringing together our research programs and market leadership with deCode's integrated approach to the genetics of common diseases, we hope to create a new paradigm for the use of DNA-based diagnostics in the treatment and prevention of these diseases,” said Heino von Prondzynski, head of Roche Diagnostics.



Related Links:
Roche Diagnostics
deCode genetics

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.